載入...
Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
Multiple myeloma (MM) is an incurable malignancy of plasma cells with a clinical course characterized by multiple relapses and treatment refractoriness. While recent treatment advancements have extended overall survival (OS), refractory MM has a poor prognosis, with a median OS of between 4 and 6 mo...
Na minha lista:
| 發表在: | Target Oncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7570401/ https://ncbi.nlm.nih.gov/pubmed/33074469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00758-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|